微芯生物：博奥生物拟减持3%股份

Core Viewpoint - The major shareholder, Bio-Ocean, plans to reduce its stake in Microchip Biotech by selling up to 12.23 million shares, which represents a maximum of 3% of the company’s total shares outstanding [1] Shareholder Reduction Plan - Bio-Ocean currently holds 34.7052 million shares, accounting for 8.51% of Microchip Biotech [1] - The planned reduction will occur within a six-month window from October 13, 2025, to April 12, 2026 [1] - The reduction will be executed through two methods: block trading (up to 8.1559 million shares) and centralized bidding (up to 4.078 million shares) [1] - In any consecutive 90-day period, the maximum reduction via block trading is limited to 2%, while centralized bidding is capped at 1% [1]